Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results
Open Access
- 20 June 2006
- journal article
- review article
- Published by Springer Nature in British Journal of Cancer
- Vol. 95 (2) , 139-145
- https://doi.org/10.1038/sj.bjc.6603226
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Chemotherapy Induces the Expression of Cyclooxygenase-2 in Non–Small Cell Lung CancerClinical Cancer Research, 2005
- Cyclooxygenase-2 protein levels are independent of epidermal growth factor receptor expression or activation in operable non-small cell lung cancerLung Cancer, 2005
- Co-expression of Cox-2 and EGFR in stage I human bronchial adenocarcinomasLung Cancer, 2004
- Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomasThe Annals of Thoracic Surgery, 2004
- COX-2, MMP-9, and Noguchi Classification Provide Additional Prognostic Information About Adenocarcinoma of the LungAmerican Journal of Clinical Pathology, 2004
- Regulation of Cyclooxgenase-2 mRNA Stability by TaxanesJournal of Biological Chemistry, 2003
- Cyclooxygenase‐2: A novel molecular target for the prevention and treatment of head and neck cancerHead & Neck, 2002
- Expression of cyclooxygenase‐1 and cyclooxygenase‐2 in bronchial epithelium and nonsmall cell lung carcinomaCancer, 2002
- Cyclooxygenase‐2 (COX‐2) mRNA Expression Levels in Normal Lung Tissues and Non‐small Cell Lung CancersJapanese Journal of Cancer Research, 1999
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985